First line treatments for common musculoskeletal conditions: establishing effectiveness and cost-effectiveness

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Dr Christine Lin is an outstanding young researcher whose research focuses on investigating the effectiveness and cost-effectiveness (value-for-money) of treatments for common musculoskeletal conditions. These conditions, such as back pain and fracture, are a major cause of disability in Australia and abroad. Dr Lin will lead a series of large clinical studies with an aim to improve patient outcomes while minimising the economic burden on the individual, health system and society.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2021

Funding Scheme: Career Development Fellowships

Funding Amount: $452,583.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical and Health Sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

back pain | clinical trial | cost-effectiveness | effectiveness | musculoskeletal disorders